IODINE-131 METHYIODOBENZYLGUANIDINE (MIBG) SCAN

DATE: 10/03/05

PROCEDURE:  After IV administration of iodine-131 MIBG, images were acquired of the following views at the following dates.

VIEWS/DATES: 24-hour anterior and posterior head/chest and pelvis/abdomen, 48-hour anterior and posterior head/chest and pelvis/abdomen.

Iodine-131 MIBG DOSE: [0.5] mCi

CORRELATIVE STUDIES: None 

COMPARISON: None

CLINICAL HISTORY: The patient is a [...]-year-old [fe]male with a history of [...]. The patient is referred to Nuclear Medicine to rule-out pheochromocytoma.

FINDINGS: Physiologic uptake of tracer is seen in nasopharynx, salivary glands, liver, urinary bladder and non-specific activity in the bowel.  No abnormal tracer uptake is seen. 

CONCLUSIONS:

Negative MIBG study with no evidence for pheochromocytoma. 

Thank you for referring this patient to the UCLA Nuclear Medicine Clinic.

I, [...], M.D., Ph.D., have reviewed this Nuclear Medicine study personally, and am in full agreement with the findings of the report presented here.